ZA983740B - Novel amidine derivatives and their use in therapy - Google Patents

Novel amidine derivatives and their use in therapy

Info

Publication number
ZA983740B
ZA983740B ZA983740A ZA983740A ZA983740B ZA 983740 B ZA983740 B ZA 983740B ZA 983740 A ZA983740 A ZA 983740A ZA 983740 A ZA983740 A ZA 983740A ZA 983740 B ZA983740 B ZA 983740B
Authority
ZA
South Africa
Prior art keywords
therapy
amidine derivatives
novel amidine
novel
derivatives
Prior art date
Application number
ZA983740A
Other languages
English (en)
Inventor
James Macdonald
James Matz
William Shakespeare
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA983740B publication Critical patent/ZA983740B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA983740A 1997-05-05 1998-05-04 Novel amidine derivatives and their use in therapy ZA983740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701682A SE9701682D0 (sv) 1997-05-05 1997-05-05 Compounds

Publications (1)

Publication Number Publication Date
ZA983740B true ZA983740B (en) 1999-02-19

Family

ID=20406836

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983740A ZA983740B (en) 1997-05-05 1998-05-04 Novel amidine derivatives and their use in therapy

Country Status (28)

Country Link
US (1) US6166030A (ja)
EP (1) EP0983266B1 (ja)
JP (1) JP2001523263A (ja)
KR (1) KR20010012227A (ja)
CN (1) CN1255130A (ja)
AR (1) AR012602A1 (ja)
AT (1) ATE210661T1 (ja)
AU (1) AU734394B2 (ja)
BR (1) BR9808725A (ja)
CA (1) CA2287999A1 (ja)
DE (1) DE69802923T2 (ja)
DK (1) DK0983266T3 (ja)
EE (1) EE9900475A (ja)
ES (1) ES2168757T3 (ja)
HU (1) HUP0003766A3 (ja)
ID (1) ID23156A (ja)
IL (1) IL132677A0 (ja)
IS (1) IS5237A (ja)
MX (1) MXPA99009874A (ja)
NO (1) NO995404L (ja)
NZ (1) NZ500676A (ja)
PL (1) PL336854A1 (ja)
PT (1) PT983266E (ja)
SE (1) SE9701682D0 (ja)
SK (1) SK140699A3 (ja)
TR (1) TR199902719T2 (ja)
WO (1) WO1998050380A1 (ja)
ZA (1) ZA983740B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566081B1 (en) 1999-10-06 2003-05-20 The Brigham And Women's Hospital, Inc. Methods of identifying a compound which modulates the non-transcriptional non-map-kinase induced effects of steroid hormones
US6683108B1 (en) * 2000-03-30 2004-01-27 Curis, Inc. Agonists of hedgehog signaling pathways and uses related thereto
US8852937B2 (en) * 2000-03-30 2014-10-07 Curis, Inc. Small organic molecule regulators of cell proliferation
US7115653B2 (en) * 2000-03-30 2006-10-03 Curis, Inc. Small organic molecule regulators of cell proliferation
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
JP5833804B2 (ja) 2005-04-13 2015-12-16 ニューラクソン,インコーポレーテッド Nos阻害活性を有する置換インドール化合物
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity
KR20100103799A (ko) 2007-11-16 2010-09-28 네우렉슨 인코포레이티드 내장통을 치료하기 위한 인돌 화합물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2169280A1 (en) * 1993-08-12 1995-02-23 Robert James Gentile Amidine derivatives with nitric oxide synthetase activities
EP0723438A1 (en) * 1993-10-04 1996-07-31 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物
CA2188680A1 (en) * 1994-05-07 1996-01-25 James Edwin Macdonald Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
KR970706272A (ko) * 1995-08-10 1997-11-03 클래스 빌헬름슨 치료에 유용한 바이시클릭 아미딘 유도체(Bicyclic Amidine Derivatives Useful in Therapy)

Also Published As

Publication number Publication date
WO1998050380A1 (en) 1998-11-12
PT983266E (pt) 2002-05-31
AU7460098A (en) 1998-11-27
EP0983266B1 (en) 2001-12-12
SE9701682D0 (sv) 1997-05-05
AR012602A1 (es) 2000-11-08
EE9900475A (et) 2000-06-15
MXPA99009874A (es) 2004-09-30
NO995404D0 (no) 1999-11-04
AU734394B2 (en) 2001-06-14
SK140699A3 (en) 2000-06-12
ATE210661T1 (de) 2001-12-15
NZ500676A (en) 2001-05-25
IL132677A0 (en) 2001-03-19
BR9808725A (pt) 2000-07-11
DK0983266T3 (da) 2002-03-11
ID23156A (id) 2000-03-23
EP0983266A1 (en) 2000-03-08
CA2287999A1 (en) 1998-11-12
CN1255130A (zh) 2000-05-31
NO995404L (no) 2000-01-05
US6166030A (en) 2000-12-26
HUP0003766A2 (en) 2001-03-28
DE69802923T2 (de) 2002-07-04
ES2168757T3 (es) 2002-06-16
TR199902719T2 (xx) 2000-02-21
PL336854A1 (en) 2000-07-17
JP2001523263A (ja) 2001-11-20
DE69802923D1 (de) 2002-01-24
HUP0003766A3 (en) 2001-09-28
KR20010012227A (ko) 2001-02-15
IS5237A (is) 1999-11-01

Similar Documents

Publication Publication Date Title
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
ZA9710339B (en) Xanthines and their therapeutic use
AP9801175A0 (en) Quinoline and quinoline compounds useful in therapy
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
ZA9811086B (en) Delivery devices and their use
GB2304309B (en) Laminate and use thereof
IL118119A0 (en) Azacycloalkane derivatives their preparation and their application in therapy
GB9712761D0 (en) Quinolines and their therapeutic use
ZA983740B (en) Novel amidine derivatives and their use in therapy
IL128902A0 (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy
GB9700490D0 (en) Improvements in and relating to members
GB9413090D0 (en) Benzazepine derivatives compositions containing them and their use in therapy
IL123535A0 (en) Benzoxazindione derivatives and their use
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
AU8727498A (en) Substituted triazine compounds and their use in medicine
ZA981374B (en) Pyridazin-3-one derivatives and their use
SI1040112T1 (en) Imidazonaphthyridines and their use in inducing cytokine biosynthesis
ZA981322B (en) Pyridazin-3-one derivatives and their use
ZA946095B (en) Amidine derivatives useful in therapy
IL134499A0 (en) Pyrimidin-2- oxy-4-one and pyrimidin-2-oxy- 4-thione derivatives
GB9715323D0 (en) Piperidinecarboxamides and their use
ZA9810117B (en) Pyridylether derivatives their preparation and use
GB9707589D0 (en) Improvements in and relating to treatment